[Home](/lab) · [Members](/lab/members) · [Projects](/lab/projects) · [Publications](/lab/publications) · [Contact](/lab/contact)

## Selected Publications

-	Luo XH*, Zhu Y, Duan XQ, Peng W, Pei CX, Yang L, Li Q, Zhao M, Wang L. Histone HIST1 genes and tumor-infiltrating lymphocytes in a child with γδ T cell acute lymphoblastic leukemia by single-cell sequencing. Journal of Leukocyte Biology. 2025 Apr;117(4):qiaf022.
-	Shui LP, Zhu Y, Duan XQ, Chen YT, Yang L, Tang XQ, Zhang HB, Xiao Q, Wang L, Liu L, Luo XH*. HBsAg (‐)/HBsAb (‐)/HBeAg (‐)/HBeAb (+)/HBcAb (+) predicts a high risk of hepatitis B reactivation in patients with B ‐ cell lymphoma receiving rituximab based immunochemotherapy. Journal of Medical Virology. 2023 Feb 3.
-	Luo XH*, Poiret T, Liu Z, Meng Q, Nagchowdhury A, Ljungman P. Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapse. Frontiers in Immunology. 2022;13.
-	Luo XH*, Zhu Y, Chen YT, Shui LP, Liu L. CMV Infection and CMV-Specific Immune Reconstitution Following Haploidentical Stem Cell Transplantation: An Update. Frontiers in immunology. 2021;12.
-	Luo XH*, Zhu Y, Mao J, Du RC. T cell immunobiology and cytokine storm of COVID‐19. Scandinavian journal of immunology. 2021 Mar;93(3):e12989.
-	Mao J, Dai R, Du RC, Zhu Y, Shui LP, Luo XH*. Hematologic changes predict clinical outcome in recovered patients with COVID-19. Annals of hematology. 2021 Mar;100(3):675-89.
-	Luo XH*, Meng Q, Liu Z, Paraschoudi G. Generation of high-affinity CMV-specific T cells for adoptive immunotherapy using IL-2, IL-15, and IL-21. Clinical Immunology. 2020 Aug 1;217:108456.
-	Li S, Huang J, Zhang YL, Zhu Y, An YF, Du J, Zhang ZL, Xia Y, Liu L, Wang L, Luo XH*. Wiskott- Aldrich syndrome protein may be critical for CD8+ T cell function following MCMV infection. Cellular immunology. 2019 Apr 1;338:43-50.
-	Zhang YL, Zhu Y, Xiao Q, Wang L, Liu L, Luo XH*. Cytomegalovirus infection is associated with AML relapse after allo-HSCT: a meta-analysis of observational studies. Annals of hematology. 2019 Apr 5;98(4):1009-20.
-	Luo XH, Meng Q, Rao M, Liu Z, Paraschoudi G, Dodoo E, Maeurer M. The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer. Immunology. 2018 Nov;155(3):294-308.
-	Zhenjiang L, Rao M, Luo X, Valentini D, von Landenberg A, Meng Q, Sinclair G, Hoffmann N, Karbach J, Altmannsberger HM, Jäger E. Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme. EBioMedicine. 2018 Jul 1;33:49-56.
-	Wang Q, Zhu Y, Li D, Xiao Q, Wang L, Liu L, Luo XH*. Concurrent mucosa-associated lymphoid tissue lymphoma with diffuse large B-cell lymphoma transformation and Hodgkin lymphoma of the neck. Annals of hematology. 2018 Jun 1;97(6):1089-94.
-	Poiret T, Axelsson-Robertson R, Remberger M, Luo XH, Rao M, Nagchowdhury A, Von Landenberg A, Ernberg I, Ringden O, Maeurer M. Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation. Frontiers in immunology. 2018 Apr 10;9:760.
-	Liu Zhenjiang, Martin Rao, Xiaohua Luo, Elisabeth Sandberg, Jiri Bartek Jr, Esther Schoutrop, Anna von Landenberg, Qingda Meng, Davide Valentini, Thomas Poiret, Georges Sinclair, Inti- Harvey Peredo, Ernest Dodoo, and Markus Maeurer*. Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis. EBioMedicine. 2017 Sep; 23: 20–24.
-	Liu Z, Poiret T, Persson O, Meng Q, Rane L, Bartek J, Karbach J, Altmannsberger HM, Illies C, Luo X, Harvey-Peredo I. NY-ESO-1-and survivin-specific T-cell responses in the peripheral blood from patients with glioma. Cancer Immunology, Immunotherapy. 2018 Feb 1;67(2):237- 46.
-	Liu Z, Meng Q, Bartek Jr J, Poiret T, Persson O, Rane L, Rangelova E, Illies C, Peredo IH, Luo X, Rao MV. Tumor-infiltrating lymphocytes (TILs) from patients with glioma. Oncoimmunology. 2017 Feb 1;6(2):e1252894.
-	Yang, B. H., Zhu, Y., Du, J., Zhang, Y. L., Li, S., Liu, L., & Luo, X. H*. Paraplegia as Manifestation of an Isolated Central Nervous System Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation in a Woman with Acute Myelogenous Leukemia. Chinese Medical Journal 2016, 129(18), 2260.
-	Xiao-Hua Luo, Xiao-Jun Huang*, Dan Li, Kai-Yan Liu, Lan-Ping Xu, Dai-Hong Liu. Immune reconstitution to cytomegalovirus following partially matched-related donor transplantation: impact of in vivo T-cell depletion and granulocyte colony-stimulating factor-primed peripheral blood/bone marrow mixed grafts. Transplant Infectious Disease 2013; 15(1):22-33
-	XH Luo, XJ Huang*, KY Liu, LP Xu, DH Liu. Protective immunity transferred by infusion of CMV- specific CD8+ T cells within donor grafts: its associations with CMV reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010; 16(7):994-1004
-	XH Luo, YJ Chang, LP Xu, DH Liu, KY Liu, XJ Huang*. The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical haematopoietic SCT. Bone Marrow Transplant 2009; 43(1):29-36.
-	Lan-Ping Xu, Xiao-Hua Luo, Ying-Jun Chang, Dai-Hong Liu, Kai-Yan Liu, Yu-Hong Chen, Xiao-Jun Huang*. Lower CD4/CD8 ratio in allografts may predict better clinical outcomes after unmanipulated HLA-mismatched/haploidentical haematopoietic stem cell transplantation for chronic myeloid leukemia. Annals of hematology. 2009; 88(10): 1015-1024.

---

### Full List

- **PubMed** →  
  [https://www.ncbi.nlm.nih.gov/myncbi/1h5SIXHYq7p/bibliography/public/](https://www.ncbi.nlm.nih.gov/myncbi/1h5SIXHYq7p/bibliography/public/)

  
- **Google Scholar** →  
  [https://scholar.google.com/citations?user=UrioBZEAAAAJ&hl=en&inst=5746887945952177237](https://scholar.google.com/citations?user=UrioBZEAAAAJ&hl=en&inst=5746887945952177237)




